Get in touch

Saudi Arabia

A new state of the art warehouse in Saudi Arabia further expanding our global reach.

 

Core service offerings include Importer of Record (IOR), storage, handling, and distribution, marking the beginning of our commitment to further support the region’s clinical trial needs.

Holiday Schedule
Flexible customer approach

Flexible customer approach

Depot able to adapt to client needs, improving services and processes to get the most out of the experience with us

State of the art warehouse

Facilities with the latest technologies and temperature control systems.

Contact information

Contact information

Address:

3933 Al Kharj Street,
Al Aziziyah Distr.,
14513, Riyadh, KSA

Other information

Other information

Depot Surface 400 sq ft

Depot type

Oximio’s Central Depots

Oximio’s Partner Depots

Products Managed

Antibiotic

Biological Goods

Blood Product or Derivative

Controlled Drugs on Request

Cytotoxic

Dangerous Goods

Genetically Modified Organism

Radioactive

Ancillary Supply/Equipment

Medicinal Cannabis Products

Temperature Conditions

Ambient (non-controlled)

Ambient (+15°C to +25°C)

Refrigerated (+2°C to +8°C)

Frozen (-25ºC to -15ºC)

Deep Frozen (-80ºC to -60ºC)

LN2 (Cryogenic)

Certifications

GDP License

GMP Certification

ISO9001:2015

MIA Certification

WHL License

Controlled Drugs License

Services

Labeling (JIT)

Secondary Packing

Comparator sourcing

IOR

DTP (direct to patient)

DTS (direct to site)

Saudi Arabia
Depot Location

Handy links to healthcare bodies across Saudi Arabia

Useful Links:

The official website of the Saudi Food and Drug Authority

View here

The Saudi National Institute of Health

View here

Useful Links:

Kingdom of Saudi Arabia Ministry of Health Portal

View here

Want to know more?

Download Oximio’s Depot Guide for more details

Download Guide download

Oximio Resources

See all resources
  • INSIGHTS    •     FEB 2026

    Why Local Pharmacovigilance Matters: The Critical Role of the LQPPV in Kenya

    Read more
  • NEWS    •     FEB 2026

    New Location Opening in Saudi Arabia – Oximio Strengthens Middle East Presence

    Read more
  • WHITE PAPER    •     FEB 2026

    Global Trends in the Clinical Supply Chain in 2026

    Read more
  • CASE STUDY    •     FEB 2026

    Quick, Compliant Turnaround of Vital Temperature Sensitive Medicinal Products in Kenya

    Read more
  • CASE STUDY    •     JAN 2026

    Oximio Kenya’s Rapid Response to Marburg Virus Outbreak in Ethiopia

    Read more

Want to stay up to date?